Launching in 1991, the In Vitro Diagnostics Division began with producing blood glucose monitoring systems with the Panasonic Group and our ODM partner.
Since the division’s carve-out from the Panasonic Group in 2014, leveraging our accumulated technological capabilities and pursuing manufacturing excellences, we have been committed to developing, manufacturing, and providing a large range of medical devices to our customers.

Strengths

- VOC(Voice of Customer)
- Listening to our customers to better understand their needs Front-loading concurrent engineering (Quality departments are involved from the planning and design stage)
- Optimized production processes